Ken Griffin Pacific Biosciences Of California, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 147,700 shares of PACB stock, worth $267,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,700

Previous 105,300 40.27%

Holding current value

$267,337

Previous $394,000 48.73%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.36 - $3.65 $786,235 - $2.11 Million	-578,114 Reduced 39.0%	904,201 $1.24 Million
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $3.3 Million - $8.99 Million	937,811 Added 172.23%	1,482,315 $5.56 Million
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $15.5 Million - $26.9 Million	-2,600,173 Reduced 82.68%	544,504 $5.34 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $6.39 Million - $10.8 Million	-776,626 Reduced 19.81%	3,144,677 $26.3 Million
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $11.2 Million - $15.8 Million	-1,127,669 Reduced 22.33%	3,921,303 $52.2 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $3.75 Million - $5.68 Million	472,312 Added 10.32%	5,048,972 $58.5 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $2.03 Million - $4.01 Million	-358,452 Reduced 7.26%	4,576,660 $37.4 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $18.2 Million - $39.6 Million	4,619,581 Added 1464.07%	4,935,112 $28.6 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $7.77 Million - $20.2 Million	-1,932,718 Reduced 85.97%	315,531 $1.4 Million
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $16 Million - $39.6 Million	1,893,895 Added 534.46%	2,248,249 $20.5 Million
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $973,573 - $1.52 Million	-50,549 Reduced 12.48%	354,354 $7.25 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $3.44 Million - $4.84 Million	138,246 Added 51.84%	404,903 $10.3 Million
Q2 2021 Aug 16, 2021	SELL	$22.3 - $36.02 $2.11 Million - $3.4 Million	-94,484 Reduced 26.16%	266,657 $9.32 Million
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $8.69 Million - $16.9 Million	329,583 Added 1044.37%	361,141 $12 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $2.87 Million - $7.8 Million	-273,698 Reduced 89.66%	31,558 $819,000
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $482,306 - $1.32 Million	133,603 Added 77.83%	305,256 $3.01 Million
Q2 2020 Aug 14, 2020	BUY	$2.65 - $4.03 $158,350 - $240,812	59,755 Added 53.4%	171,653 $592,000
Q1 2020 May 15, 2020	BUY	$2.36 - $5.26 $190,093 - $423,682	80,548 Added 256.93%	111,898 $342,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $57,495 - $69,619	12,499 Added 66.3%	31,350 $161,000
Q3 2019 Nov 14, 2019	SELL	$4.99 - $6.16 $21.6 Million - $26.7 Million	-4,333,652 Reduced 99.57%	18,851 $97,000
Q2 2019 Feb 14, 2020	BUY	$5.92 - $7.41 $25.4 Million - $31.8 Million	4,287,701 Added 6616.62%	4,352,503 $26.3 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $15.3 Million - $19.1 Million	-2,581,863 Reduced 97.55%	64,802 $392,000
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $17.9 Million - $19.4 Million	2,626,918 Added 13302.87%	2,646,665 $0
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $135,045 - $264,675	-33,846 Reduced 63.15%	19,747 $146,000
Q3 2018 Nov 13, 2018	SELL	$3.52 - $5.55 $2.1 Million - $3.31 Million	-597,075 Reduced 91.76%	53,593 $0
Q2 2018 Aug 10, 2018	BUY	$2.11 - $3.92 $378,156 - $702,546	179,221 Added 38.02%	650,668 $0
Q1 2018 May 11, 2018	BUY	$2.05 - $3.23 $722,573 - $1.14 Million	352,475 Added 296.27%	471,447 $967,000
Q4 2017 Feb 09, 2018	BUY	$2.59 - $5.44 $259,626 - $545,316	100,242 Added 535.19%	118,972 $314,000
Q3 2017 Nov 09, 2017	BUY	$3.2 - $5.57 $59,936 - $104,326	18,730	18,730 $98,000

Others Institutions Holding PACB

# of Institutions

258

Shares Held

234M

Call Options Held

1.02M

Put Options Held

965K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $407M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account